Skip to content

A study to check the combined actions of Bala oil nasal wick and intake of Bala oil in the treatment of Deviated nasal septum

Pre and post test study to assess the combined effect of Balataila nasavarthi and Balataila pana in the management of symptomatic deviated nasal septum (Nasanaha)

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012315
Enrollment
30
Registered
2018-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- symptomatic deviated nasal septum

Interventions

Intervention1: bala taila: condition with deviated nasal septum balataila-Dose 10ml nasally 5-10 ml orally route of administration -nasal and Oral Route Duration -28 Days Control Intervention1: not a

Sponsors

Aswin T Das
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age-12-35yrs Satisfying the diagnostic criteria Either sex Patient with symptoms of DNS like Nasal blockage and Head ache S Shaped and C Shaped deformity Having visible external deformity is also selected.

Exclusion criteria

Exclusion criteria: Patient suffering from any systemic diseases &receiving medication Patient having Asthma, respiratory tract infection, nasal polyp, epistaxis Other Anterior Dislocation, Septal spur, Septal perforation are excluded. Patient underwent Septoplasty is excluded.

Design outcomes

Primary

MeasureTime frame
relief from symptomsTimepoint: one months

Secondary

MeasureTime frame
efficacy of the treatmentTimepoint: 6 months

Countries

India

Contacts

Public ContactDr K Sivabalaji

Amrita School Of Ayurveda

balajisiva85k@gmail.com7559027947

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026